Skip to main content
SpringerLink
Log in

Introduction to Substance Use Disorders for the Eating Disorder Specialist

  • Chapter
  • First Online:
Eating Disorders, Addictions and Substance Use Disorders

  • 3675 Accesses

Abstract

Substance use disorders and eating disorders co-occur frequently; however, currently, there are no evidence-based treatments to guide the practitioner faced with this comorbid condition. Very few eating disorder programs have incorporated substance abuse protocols into their programs, and likewise, few substance abuse programs can effectively treat the patient with a serious eating disorder. Consequently, clinicians presented with these patients tend to focus on their area of specialty without addressing directly the other comorbid condition. Inadvertently, this can prolong the patient’s suffering as they vacillate between their substance use disorder and their eating disorder. The intention of this chapter is to provide a brief overview of substance use disorders for students, clinicians, and researchers in the health and mental health field. It was specifically designed for the eating disorder specialist that has limited knowledge of the psychoactive properties of drugs of abuse, the clinical characteristics of individuals with alcohol and drug abuse problems, the philosophy and/or vernacular of abstinence-based models (e.g., Alcoholics Anonymous [AA], Narcotics Anonymous [NA], or Cocaine Anonymous [CA]), and other evidence-based models/approaches for the treatment of substance use disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agrawal, A., & Lynskey, M. (2006). The genetic epidemiology of cannabis use, abuse and dependence. Addiction, 101, 801–812.

    PubMed  Google Scholar 

  • American Diabetes Association. (2008). Nutrition recommendations and intervention for diabetes. Diabetes Care, 31, 561–578.

    Google Scholar 

  • American Psychiatric Association (2006). American Psychiatric Association Practice Guidelines for the treatment of psychiatric disorders: Compendium 2006. American Psychiatric Pub.

    Google Scholar 

  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: American Psychiatric Association.

    Google Scholar 

  • Anthony, J. (2006). The epidemiology of cannabis dependence. In R. Roffman & R. Stephens (Eds.), Cannabis dependence: Its nature, consequences and treatment (pp. 58–95). Cambridge, UK: Cambridge University Press.

    Google Scholar 

  • Baker, J., Mitchell, K., Neale, M., & Kendler, K. (2010). Eating disorder symptomatology and substance use disorders: Prevalence and shared risk in a population based twin sample. International Journal of Eating Disorders, 43, 648–658.

    PubMed Central  PubMed  Google Scholar 

  • Baum, A. (2000). Psychopharmacology in athletes. In D. Begel & R. Burton (Eds.), Sport psychiatry: Theory and practice (pp. 249–259). New York: WW Norton & Co.

    Google Scholar 

  • Beck, A. T. (1963). Thinking and depression: Idiosyncratic content and cognitive distortions. Archives of General Psychiatry, 9, 324–333.

    CAS  PubMed  Google Scholar 

  • Bickel, W., Amass, L., Higgins, S., Badger, G., & Esch, R. (1997). Effects of adding behavioral treatment to opioid detoxification with buprenorphine. Journal of Consulting and Clinical Psychology, 65, 803–810.

    CAS  PubMed  Google Scholar 

  • Biederman, J., Ball, S., Monuteaus, M., Surman, L., Johnson, J., & Zetlin, S. (2007). Are girls with ADHD at risk for eating disorders? Results from a controlled, five-year prospective study. Journal of Developmental and Behavioral Pediatrics, 28, 302–307.

    PubMed  Google Scholar 

  • Blouin, J., Carter, J., Blouin, A., Tener, L., Schnare-Hayes, K., Zuro, C., … Perez, E. (1994). Prognostic indicators in bulimia nervosa treated with cognitive-behavioral group therapy. International Journal of Eating Disorders, 15, 113–123.

    Google Scholar 

  • Breier, A., & Paul, S. (1990). The GABAA benzodiazepine receptor: Implications for the molecular basis of anxiety. Journal of Psychiatric Research, 24, 91–104.

    PubMed  Google Scholar 

  • Brook, D., Brook, J., Zhang, C., & Koppel, J. (2010). Association between attention-deficit/hyperactivity disorder in adolescence and substance use disorders in adulthood. Archives of Pediatric Adolescent Medicine, 164, 930–934.

    Google Scholar 

  • Brownstein, M. (1993). A brief history of opiates, opioid peptides, and opioid receptors. Proceeding of the National Academy of Sciences of the United States of America, 90, 5391–5393.

    CAS  Google Scholar 

  • Bryant-Waugh, R., Turner, H., East, P., Gamble, C., & Mehta, R. (2006). Misuse of laxatives among adult outpatients with eating disorders: Prevalence and profiles. International Journal of Eating Disorders, 39, 404–409.

    PubMed  Google Scholar 

  • Budney, A., Vandrey, R., & Fearer, S. (2011). Cannabis. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 214–237). Philadelphia, PA: Lippincott Williams and Wilkins.

    Google Scholar 

  • Carroll, K. (2011). Cognitive behavioral therapy. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 593–602). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Carroll, K., Rounsaville, B., Nich, C., & Gordon, L. (1994). One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence: Delayed emergence of psychotherapy effects. Archives of General Psychiatry, 51, 177–197.

    CAS  PubMed  Google Scholar 

  • Ciccarone, D. (2011). Stimulant abuse: Pharmacology, cocaine, methamphetamine, treatment, attempts at pharmacotherapy. Primary Care, 38, 41–58.

    PubMed Central  PubMed  Google Scholar 

  • Ciraulo, D., & Knapp, C. (2011). Sedative-hypnotics. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 255–266). Philadelphia, PA: Lippincott Williams and Wilkins.

    Google Scholar 

  • Cochrane, C., Malcolm, R., & Brewerton, T. (1998). The role of weight control as a motivation for cocaine abuse. Addictive Behaviors, 23, 201–207.

    CAS  PubMed  Google Scholar 

  • Colton, P., Rodin, G., Bergenstal, R., & Parkin, C. (2009). Eating disorders and diabetes: Introduction and overview. Diabetes Spectrum, 22, 138–142.

    Google Scholar 

  • Colton, P., & Woodside, D. B. (1999). Laxative withdrawal in eating disorders: Treatment protocol and 3 to 20-month follow-up. International Journal of Eating Disorders, 25, 311–317.

    CAS  PubMed  Google Scholar 

  • Compton, W., Conway, K., Stinson, F., Colliver, J., & Grant, B. (2005). Prevalence, correlates and comorbidity of DSM-IV antisocial personality syndromes and specific substance use disorders in the United States: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 66, 677–685.

    PubMed  Google Scholar 

  • Compton, W., Thomas, Y., Stinson, F., & Grant, B. (2007). Prevalence, correlates, disability and comorbidity of DSM-IV drug abuse and dependence in the United States. Archives of General Psychiatry, 64, 566–576.

    PubMed  Google Scholar 

  • Connery, H. S., & Kleber, H. D. (2007). Guideline Watch (April 2007): Practice guideline for the treatment of patients with substance use disorders. FOCUS: The Journal of Lifelong Learning in Psychiatry, 5, 163–166.

    Google Scholar 

  • Consumer Reports Magazine (2012, September). 10 surprising dangers of vitamins and supplements: Don’t assume they’re safe because they’re ‘all natural’. Retrieved from consumerreports.org.

    Google Scholar 

  • Copeland, J., & Swift, W. (2009). Cannabis use disorder: Epidemiology and management. International Review of Psychiatry, 21, 96–103.

    PubMed  Google Scholar 

  • Copeland, J., Swift, W., Roffman, R., & Stephans, R. (2001). A randomized controlled trial of brief cognitive-behavioral interventions of cannabis use disorder. Journal of Substance Abuse Treatment, 21, 55–64.

    CAS  PubMed  Google Scholar 

  • Crow, S., Mitchell, J., & Kendall, D. (1997). Levothyroxine abuse in bulimia nervosa. Psychosomatic Medicine, 38, 151–153.

    CAS  Google Scholar 

  • DCCT Research Group. (2001). Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial. Diabetes Care, 24, 1711–1721.

    Google Scholar 

  • Degenhardt, L., Dieker, L., Chiu, W. T., Medina-Mora, E. E., Neumark, Y., Sampson, N., … Kessler, R. (2010). Evaluating the drug use “gateway” theory using cross-national data: Consistency and associations of the order of initiation of drug use among participants in the WHO World Mental Health Surveys. Drug and Alcohol Dependence, 108, 84–97.

    Google Scholar 

  • Dennis, A. B., & Helfman, B. (2010). Managing the eating disorder patient with a comorbid substance use disorder. In M. Maine, B. McGilley, & D. Bunnell (Eds.), Treatment of eating disorders: Bridging the research-practice gap (pp. 233–249). London, UK: Elsevier.

    Google Scholar 

  • Dennis, A. B., & Sansone, R. A. (in press). Issues in treating comorbidity in the eating disorders. In M. Levine, & L. Smolak (Eds.), Wiley-Blackwell handbook of eating disorders (pp. x–x). London, UK: Wiley.

    Google Scholar 

  • DeWit, D. J., Adlaf, E. M., Offord, D. R., & Ogbourne, A. C. (2000). Age at first alcohol use: A risk factor for the development of alcohol disorders. American Journal of Psychiatry, 157, 745–750.

    CAS  PubMed  Google Scholar 

  • DiClemente, C., Kofeldt, M., & Gemmell, L. (2011). Motivational enhancement. In M. Galanter & H. Kleber (Eds.), Psychotherapy for the treatment of substance abuse (pp. 125–152). Washington, DC: American Psychiatric Publishing.

    Google Scholar 

  • DiClemente, C., Van Orden, O., & Wright, K. (2011). Motivational interviewing and enhancement. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 622–632). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Donovan, D., Daley, D., Brigham, G., Hodgkins, C., Perl, H., Garrett, S., … Zammarelli, L. (2013). Stimulant abuser groups to engage in 12-step: A multisite trial in the National Institute on Drug Abuse Clinical Trials Network. Journal of Substance Abuse Treatment, 44, 103–114.

    Google Scholar 

  • Ellis, A. (1962). Reason and emotion in psychotherapy. New York: Lyle Stuart.

    Google Scholar 

  • Epstein, D., Phillips, K., & Preston, K. (2011). Opioids. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 161–190). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Favaro, A., & Santtonastaso, P. (1998). Impulsive and compulsive self-injurious behaviors in bulimia nervosa: Prevalence and psychological correlates. Journal of Nervous and Mental Diseases, 186, 157–165.

    CAS  Google Scholar 

  • Fontaine, R., Beaudry, P., Le Morvan, P., Beauclair, L., & Chouinard, G. (1990). Zopiclone and triazolam in insomnia associated with generalized anxiety disorder: A placebo-controlled evaluation of efficacy and daytime anxiety. International Clinical Psychopharmacology, 5, 173–183.

    CAS  PubMed  Google Scholar 

  • Fornari, V., Edleman, R., & Katz, J. (1990). Medication manipulation in bulimia nervosa: An additional diagnostic criterion? International Journal of Eating Disorders, 9, 585–588.

    Google Scholar 

  • Garbutt, J., West, S., Carey, T., Lohr, K., & Crews, F. (1999). Pharmacological treatment of alcohol dependence. Journal of the American Medical Association, 281, 1318–1325.

    CAS  PubMed  Google Scholar 

  • Gardner, E. (2005). Endocannabinoid signaling system and brain reward: Emphasis on dopamine. Pharmacology Biochemistry and Behavior, 81, 263–284.

    CAS  Google Scholar 

  • Gastfriend, D., & Mee-Lee, D. (2011). Patient placement criteria. In M. Galanter & H. Kleber (Eds.), Psychotherapy for the treatment of substance abuse (pp. 99–124). Washington, DC: American Psychiatric Publications.

    Google Scholar 

  • Glantz, M., Anthony, J., Berglund, P., Degenhardt, L., Dierker, L., Kalaydjian, A., … Kessler, R. (2009). Mental disorders as risk factors for later substance dependence. Psychological Medicine, 39, 1365–1377.

    Google Scholar 

  • Grant, B., Chou, P., Goldstein, R., Huang, B., Stinson, F., Saha, T., … Ruan, W. (2008). Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: Results from the wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Journal of Clinical Psychiatry, 69, 533–545.

    Google Scholar 

  • Green, J., McLaughlin, K., Berlund, P., Gruber, M., Sampson, N., Zaslavsky, A., & Kessler, R. (2010). Childhood adversities and adult psychiatric disorders in the National Comorbidity Survey Replication I: Associations with first onset of DSM-IV disorders. Archives of General Psychiatry, 67, 113–123.

    Google Scholar 

  • Hamid, H., El-Maliakh, R., & Vandeveir, K. (2005). Substance abuse: Medical and slang terminology. Southern Medical Journal, 98, 350–362.

    PubMed  Google Scholar 

  • Helzer, J., & Pryzbeck, T. (1988). The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. Journal of Studies on Alcohol and Drugs, 49, 219–224.

    CAS  Google Scholar 

  • Hendricks, E., & Greenway, F. (2011). A study of abrupt phentermine cessation in patients in a weight management program. American Journal of Therapeutics, 18, 292–299.

    PubMed  Google Scholar 

  • Herpertz, S., Albus, C., & Kielman, R. (2001). Comorbidity of diabetes and eating disorders: A follow-up study. Journal of Psychosomatic Research, 51, 673–678.

    CAS  PubMed  Google Scholar 

  • Hicks, B., Durbin, E., Blonigen, D., Iacono, W., & McGue, M. (2012). Relationship between personality change and the onset and course of alcohol dependence in young adulthood. Addiction, 107, 540–548.

    PubMed Central  PubMed  Google Scholar 

  • Higgins, S., Budney, A., Bickel, W., Hughes, J., Foerg, F., & Badger, G. (1992). Achieving cocaine abstinence with a behavioral approach. American Journal of Psychiatry, 150, 763–769.

    Google Scholar 

  • Higgins, S., Sigmon, S., & Heil, S. (2011). Contingency management in the treatment of substance use disorders: Trends in the literature. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 603–621). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Higgins, S., Silverman, K., & Heil, S. (2008). Contingency management in substance abuse treatment. New York, NY: Guilford.

    Google Scholar 

  • Hill, K., & Weiss, R. (2011). Amphetamines and other stimulants. In P. Ruiz & E. Strain (Eds.), Lowenson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 238–254). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Himmelsbach, C. (1942). Clinical studies of drug addiction. Archives of Internal Medicine, 69, 766–772.

    Google Scholar 

  • Hofmann, S., Asnaani, A., Imke, J., Vonk, I., Sawyer, A., & Fang, A. (2012). The efficacy of cognitive behavioral therapy: A review of meta-analyses. Cognitive Therapy and Research, 36, 427–440.

    PubMed Central  PubMed  Google Scholar 

  • Jaffe, J. (1992). Opiates: Clinical aspects. In J. Lowinson, P. Ruiz, & R. Millman (Eds.), Lowenson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 186–194). Baltimore, MD: Williams and Wilkins.

    Google Scholar 

  • Jaffe, J., & Martin, W. (1991). Opioid analgesics and antagonists. In A. Gilman, T. Rall, & A. Nies (Eds.), The pharmacological basis of therapeutics (8th ed.). New York: Pergamon.

    Google Scholar 

  • Jeffers, A., Benotsch, E., & Koester, S. (2013). Misuse of prescription stimulants for weight loss, psychosocial variables, and eating disordered behaviors. Appetite, 65, 8–13.

    PubMed  Google Scholar 

  • Jennison, K., & Johnson, K. (2001). Parental alcoholism as a risk factor for DSM-IV defined alcohol abuse and dependence in American women: The protective benefits of dyadic cohesion in marital communications. American Journal of Drug and Alcohol Abuse, 27, 349–374.

    CAS  PubMed  Google Scholar 

  • Johnson, C., Powers, P., & Dick, R. (1999). Athletes and eating disorders: The national collegiate athletic association study. International Journal of Eating Disorders, 26, 179–188.

    CAS  PubMed  Google Scholar 

  • Johnson, C., Tobin, D., & Enright, A. (1989). Prevalence and clinical characteristics of borderline patients in an eating disordered population. Journal of Clinical Psychiatry, 50, 133–138.

    Google Scholar 

  • Kanayama, G., Hudson, J., & Pope, H. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: A looming public health concern? Drug and Alcohol Dependence, 98, 1–12.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Kandel, D., Yamaguchi, K., & Chen, K. (1992). Stages of progression in drug involvement from adolescence to adulthood: Further evidence for the gateway theory. Journal of Studies on Alcohol and Drugs, 53, 447–457.

    CAS  Google Scholar 

  • Kendler, K., Jacobson, K., Prescott, C., & Neale, M. (2003). Specificity of genetic and environmental risk factors for use and abuse/dependence of cannabis, cocaine, hallucinogens, sedatives, stimulants and opiates in male twins. American Journal of Psychiatry, 160, 687–695.

    PubMed  Google Scholar 

  • Kendler, K., Prescott, C., Myers, J., & Neale, M. (2003). The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Archives of General Psychiatry, 60, 929–937.

    PubMed  Google Scholar 

  • Klein, D., Boudreau, G., Devlin, M., & Walsh, B. T. (2006). Artificial sweetener use among individuals with eating disorders. International Journal of Eating Disorders, 39, 341–345.

    PubMed  Google Scholar 

  • Kraemer, H. C., Kazdin, A. E., Offord, D. R., Kessler, R. C., Jensen, P. S., & Kupfer, D. J. (1997). Coming to terms with the terms of risk. Archives of General Psychiatry, 54, 337–343.

    CAS  PubMed  Google Scholar 

  • Krebs, T., & Johansen, P. (2012). Lysergic acid diethylamide (LSD) for alcoholism: Meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26, 994–1002.

    PubMed  Google Scholar 

  • Leary, T. (1997). Flashbacks: An autobiography. Los Angeles, CA: Jeremy P. Tarcher.

    Google Scholar 

  • Linehan, M., Dimeff, L., Reynolds, S., Comtois, K., Welch, S., Heagerty, P., & Kivlahan, D. (2002). Dialectical behavior therapy versus comprehensive validation therapy plus 12-step for the treatment of opioid dependent women meeting criteria for borderline personality disorder. Drug and Alcohol Dependence, 67, 13–26.

    Google Scholar 

  • Linehan, M. M., Schmidt, J., Dimeff, L., Craft, J. C., Kanter, J., & Comtois, K. (1999). Dialectical behavior therapy for patients with borderline personality disorder and drug-dependence. The American Journal of Addictions, 8, 279–292.

    CAS  Google Scholar 

  • Longabaugh, R., Wirtz, P. W., Beattie, M. C., Noel, N., & Stout, R. (1995). Matching treatment focus to patient social investment and support: 18 month follow-up results. Journal of Consulting and Clinical Psychology, 63, 296–307.

    CAS  PubMed  Google Scholar 

  • Maddocks, S., & Kaplan, A. (1991). The prediction of treatment response in bulimia nervosa. British Journal of Psychiatry, 159, 846–849.

    CAS  PubMed  Google Scholar 

  • Marlowe, A. (1994). Listening to heroin: What dope says about pleasure, poison, and keeping score. Village Voice, pp. 25–30.

    Google Scholar 

  • Mascolo, M., Chu, E., & Mehler, P. (2011). Abuse and clinical value of diuretics in eating disorders therapeutic applications. International Journal of Eating Disorders, 44, 100–202.

    Google Scholar 

  • McCabe, S., Teter, C., & Boyd, C. (2006). Medical use, illicit use and diversion of prescription stimulant medication. Journal of Psychoactive Drugs, 38, 43–56.

    PubMed Central  PubMed  Google Scholar 

  • McCann, U. (2011). PCP/Designer drugs/MDMA. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 277–283). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • McDuff, D., & Baron, D. (2005). Substance use in athletics: A sports psychiatry perspective. Clinical Sports Medicine, 24, 885–897.

    Google Scholar 

  • McGue, M. (1999). The behavioral genetics of alcoholism. Current Directions in Psychological Science, 8, 109–115.

    Google Scholar 

  • McLaughlin, K., Green, J., Gruber, M., Sampson, N., Zalavsky, A., & Kessler, R. (2010). Childhood adversities and adult psychiatric disorders in the National Comorbidity Survey Replication II: Associations with persistence of DSM-IV disorders. Archives of General Psychiatry, 67, 124–132.

    PubMed Central  PubMed  Google Scholar 

  • Mee-Lee, D., Shulman, G., Fishman, M., Gastfriend, D., & Griffith, J. (2001). ASAM patient placement criteria or treatment of substance-related disorders. (2nd Ed., revised) (ASAM PPC-2R). Chevy Chase, MD: American Society of Addiction Medicine.

    Google Scholar 

  • Miller, W. R. (1983). Motivational interviewing with problem drinkers. Behavioural Psychotherapy, 11, 147–172.

    Google Scholar 

  • Miller, W., & Rose, G. (2009). Toward a theory of motivational interviewing. American Psychologist, 64, 527–537.

    PubMed Central  PubMed  Google Scholar 

  • Miller, W., & Wilbourne, P. (2002). Mesa Grande: A methodological analysis of clinical trials of treatments for alcohol use disorders. Addictions, 97, 265–277.

    Google Scholar 

  • Mitchell, J. E., Boutacoff, L. I., Hatsukami, D., Pyle, R. L., & Eckert, E. D. (1986). Laxative abuse as a variant of bulimia. Journal of Nervous and Mental Disease, 174, 174–176.

    CAS  PubMed  Google Scholar 

  • Mitchell, J., Pomeroy, C., & Huber, M. (1988). A clinician’s guide to the eating disorder medicine cabinet. International Journal of Eating Disorders, 7, 211–223.

    Google Scholar 

  • Mitchell, J., Specker, S., & Edmonson, K. (1997). Management of substance abuse and dependence. In D. Garner & P. Garfinkel (Eds.), Handbook of treatment for eating disorders (pp. 415–423). New York: Guilford.

    Google Scholar 

  • Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of {+/−}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of Psychopharmacology, 25(4), 439–452.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Mithoefer, M.C., Wagner, M.T., Mithoefer, A.T., Jerome, L., Martin, S.F., Yazar-Klosinski, B., … Doblin, R. (2013). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of Psychopharmacology, 27(1), 28–39.

    Google Scholar 

  • Monti, P., Rohsenow, D., Michalec, E., Martin, R., & Abrams, D. (1997). Brief coping skills treatment for cocaine abuse: Substance use outcomes at three months. Addiction, 92, 1717–1728.

    CAS  PubMed  Google Scholar 

  • Moos, R. H., & Timko, C. (2008). Outcome research on 12-step and other self-help programs. In M. Galanter & H. Kleber (Eds.), The American Psychiatric Publishing textbook of substance abuse treatment (pp. 511–521). Washington, DC: American Psychiatric Publishing.

    Google Scholar 

  • Moreno, F., Wiegand, C., Tatano, E., & Delgado, P. (2006). Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder. Journal of Clinical Psychiatry, 67, 1735–1740.

    CAS  PubMed  Google Scholar 

  • Morgenstern, J., & Longabaugh, R. (2000). Cognitive-behavioral treatment for alcohol dependence: A review of the evidence for its hypothesized mechanisms of action. Addiction, 95, 1475–1490.

    CAS  PubMed  Google Scholar 

  • MTP Research Group. (2004). Treating cannabis dependence: Findings from a multisite study. Journal of Consulting and Clinical Psychology, 72, 455–466.

    Google Scholar 

  • National Institute on Drug Abuse. (2012). Synthetic cathinones (“Bath Salts”). Retrieved August 10, 2013, from U.S. Department of Health and Human Services: www.drugabuse.gov/sites/defult/files/drugfacts_bath_salts_final_0_1.pdf.

  • Nelson, T. (1990). Serenity: A companion for Twelve Step Recovery, complete with New Testament, Psalms & Proverbs. Nashville, TN: Thomas Nelson.

    Google Scholar 

  • Nielsen, S. (2002). Eating disorders in females with type I diabetes: An update of a meta-analysis. European Eating Disorders Review, 10(4), 241–254.

    Google Scholar 

  • Nowinski, J., Baker, S., & Carroll, K. (1995). Twelve-step facilitation therapy manual. Rockville, MD: National Institute on Alcohol Abuse and Alcoholism.

    Google Scholar 

  • O’Brien, C. P., & McKay, J. (2007). Psychopharmacological treatments for substance use disorders. In P. E. Nathan & J. M. Gorman (Eds.), A guide to treatments that work (3rd ed., pp. 145–177). New York: Oxford University Press.

    Google Scholar 

  • Ohlrich, E., Aughey, D., & Dixon, R. (1989). Sorbitol abuse among eating disordered patients. Psychosomatics, 30, 451.

    CAS  PubMed  Google Scholar 

  • Osher, C. N. (2010, 3-January). As dispensaries pop up, Denver may be pot capital, U.S.A. From DenverPost.com: http://www.denverpost.com/ci_14112792.

  • Pechnick, R., & Cunningham, K. (2011). Hallucinogens. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 267–276). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Pollack, M., Penava, S., Bolton, E., Worthington, J., Allen, G., Farach, F., & Otto, M. (2002). A novel cognitive-behavioral approach for treatment-resistant drug dependence. Journal of Substance Abuse Treatment, 23, 335–342.

    Google Scholar 

  • Pomeroy, C., Mitchell, J., Seim, H., & Seppala, M. (1998). Prescription diuretic abuse in patients with bulimia nervosa. Journal of Family Practice, 27, 493–496.

    Google Scholar 

  • Pryor, T., Wiederman, M. W., & McGilley, B. (1996). Laxative abuse among women with eating disorders: An indication of psychopathology? International Journal of Eating Disorders, 20, 13–18.

    CAS  PubMed  Google Scholar 

  • Ptacek, R., Kuzelova, H., & Stepankova, T. (2010). Attention deficit hyperactivity disorder and eating disorders. Prague Medical Report, 111, 175–181.

    CAS  PubMed  Google Scholar 

  • Puchalski, C. M., Dorff, R. E., & Hendi, I. Y. (2004). Spirituality, religion, and healing in palliative care. Clinical Geriatric Medicine, 20, 689–714.

    Google Scholar 

  • Ries, R., Galanter, M., Tonigan, J. S., & Ziegler, P. (2011). Twelve-step facilitation for co-occurring addiction and mental health disorders. In M. Galanter & H. D. Kleber (Eds.), Psychotherapy for the treatment of substance abuse (pp. 299–328). Washington, DC: American Psychiatric Publishing.

    Google Scholar 

  • Roerig, J., Mitchell, J., & de Zwaan, M. (2003). The eating disorders medicine cabinet revisited: A clinician’s guide to appetite suppressants and diuretics. International Journal of Eating Disorders, 33, 443–457.

    PubMed  Google Scholar 

  • Rosenthal, R. (2011). Alcohol abstinence management. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 477–493). Philadelphia, PA: Lippincott Williams and Wilkins.

    Google Scholar 

  • SAMHSA. (2004). Gender differences in alcohol use and alcohol dependence or abuse: 2004 & 2005. Rockville: Office of Applied Studies.

    Google Scholar 

  • SAMHSA. (2005). Substance abuse treatment for persons with co-occurring disorders: Treatment improvement protocol (TIP) 42. Health and Human Services, Center for Substance Abuse Treatment (CSAT), Rockville, MD.

    Google Scholar 

  • SAMHSA. (2012). Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-41, HHS Publication No (SMA) 11-4658. Rockville, MD: Substance Abuse and Mental Health Services Administration.

    Google Scholar 

  • Sara, G., Burgess, P., Harris, M., Malhi, G., Whiteford, H., & Hall, W. (2012). Stimulant use disorders: Characteristics and comorbidity in an Australian population sample. Australian and New Zealand Journal of Psychiatry, 46, 1173–1181.

    PubMed  Google Scholar 

  • Saxon, A., & Miotto, K. (2011). Methadone maintenance. In P. Ruiz & E. Strain (Eds.), Lowinson and Ruiz’s Substance abuse: A comprehensive textbook (pp. 419–436). Philadelphia, PA: Lippincott Williams & Wilkins.

    Google Scholar 

  • Schmidt, U., & O’Donoghue, G. (1992). Bulimia nervosa in thyroid disorder. International Journal of Eating Disorders, 12, 93–96.

    Google Scholar 

  • Schmitz, J., Averill, P., Sayre, S., McCleary, P. M., & Swann, A. (2002). Cognitive-behavioral treatment of bipolar disorder and substance abuse: A preliminary randomized study. Addictive Disorders and Their Treatment, 1, 17–24.

    Google Scholar 

  • Schuckit, M. (2006). Drug and alcohol abuse: A clinical guide to diagnosis and treatment (6th ed.). New York: Springer.

    Google Scholar 

  • Schuckit, M., Smith, T., Kramer, J., Danko, G., & Volpe, F. (2002). The prevalence and clinical course of sedative-hypnotic abuse and dependence in a large cohort. The American Journal of Drug and Alcohol Abuse, 28, 73–90.

    PubMed  Google Scholar 

  • Sewell, R., Halpern, J., & Pope, H. (2006). Response of cluster headache to psilocybin and LSD. Neurology, 66, 1920–1922.

    PubMed  Google Scholar 

  • Sneader, W. (1998). The discovery of heroin. Lancet, 352(9141), 1697–1699.

    CAS  PubMed  Google Scholar 

  • Solowij, N., Stephens, R., Roffman, R., Babor, T., Kadden, R., Miller, M., … Vendetti, J. (2002). Cognitive functioning of long-term heavy cannabis users seeking treatment. Journal of the American Medical Association, 287, 1123–1131.

    Google Scholar 

  • Steffen, K., Mitchell, J., Le Grange, D., Crow, S., Attia, E., Bulik, C., … Bansal-Dev, V. (2010). A prevalence study and description of alli use by patients with eating disorders. International Journal of Eating Disorders, 43, 472–479.

    Google Scholar 

  • Steffen, K., Mitchell, J., & Roerig, J. (2007). The eating disorder medicine cabinet revisited: A clinician’s guide to Ipecac and laxatives. International Journal of Eating Disorders, 40, 360–368.

    PubMed  Google Scholar 

  • Stone, J., Zorick, T., & Tsuang, J. (2007). Dose-related illusions and hallucinations with zaleplon. Clinical Toxicology, 46, 1–2.

    Google Scholar 

  • Stotts, A., Dodrill, C., & Kosten, T. (2009). Opioid dependence treatment: Options in pharmacotherapy. Expert Opinion on Pharmacotherapy, 10, 1727–1740.

    CAS  PubMed Central  PubMed  Google Scholar 

  • Strother, E., Lemberg, R., Stanford, S. C., & Turberville, D. (2012). Eating disorders in men: Underdiagnosed, undertreated and misunderstood. Eating Disorders: Journal of Treatment and Prevention, 20, 346–355.

    Google Scholar 

  • Sundgot-Borgen, J., & Torstveit, M. (2004). Prevalence of eating disorders in elite athletes is higher than in the general population. Clinical Journal of Sport Medicine, 14, 24–32.

    Google Scholar 

  • Swendsen, J., Conway, K., Degenhardt, L., Glantz, M., Jin, R., Merikangas, K., … Kessler, R. (2010). Mental disorders as risk factors for substance use, abuse and dependence: Results for the 10-year follow-up of the National Comorbidity Survey. Addiction, 105, 1117–1128.

    Google Scholar 

  • Teter, C., McCabe, S., Cranford, J., Boyd, C., & Guthrie, S. (2005). Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health, 53, 253–262.

    PubMed  Google Scholar 

  • Titan Pharmaceuticals (2013). Titan pharmaceuticals receives complete response letter from the FDA for probuphine new drug application. Press release. Retrieved from http://www.titanpharm.com/press/2013/13-04-30-Titan-CRL.htm

  • Tobin, D., Johnson, C., & Dennis, A. B. (1992). Divergent forms of purging behavior in bulimia nervosa patients. International Journal of Eating Disorders, 11, 17–24.

    Google Scholar 

  • Touitou, Y. (2007). Sleep disorders and hypnotic agents: Medical, social and economical impact. Annales Pharmaceutiques Francaises, 65(4), 230–238.

    CAS  PubMed  Google Scholar 

  • Tsuang, M. T., Bar, J. L., Harley, R. M., & Lyon, M. J. (2001). The Harvard twin study of substance abuse: What we have learned. The Harvard Review of Psychiatry, 9, 267–279.

    CAS  Google Scholar 

  • Tuttle, J., Scheurich, N., & Ranseen, J. (2010). Prevalence of ADHD diagnosis and nonmedical prescription stimulant use in medical students. Academic Psychiatry, 34, 220–223.

    PubMed  Google Scholar 

  • United Nations Office on Drugs and Crime. (2006). Cannabis: Why should we care? In 2006 World drug report: Analysis (Vol.1) (pp. 156–171). United Nations Publications.

    Google Scholar 

  • Veilleux, J., Colvin, P., Anderson, J., York, C., & Heinz, A. (2010). A review of opioid dependence treatment: Pharmacological and psychosocial interventions to treat opioid addiction. Clinical Psychological Review, 30, 155–166.

    Google Scholar 

  • Waid, L., LaRowe, S., Anton, R., & Johnson, D. (2004). Attention deficit hyperactivity disorder and substance abuse. In H. K. Tinsley (Ed.), Dual diagnosis and psychiatric treatment: Substance abuse and comorbid disorders (2nd ed., pp. 349–386). New York: Marcell Dekker.

    Google Scholar 

  • Waller, D. A., Newton, P. A., Hardy, B. W., & Svetlik, D. (1990). Correlates of laxative abuse in bulimia. Hospital and Community Psychiatry, 41, 797–799.

    CAS  PubMed  Google Scholar 

  • Wiederman, M. W., & Pryor, T. (1996). Multi-impulsivity among women with bulimia nervosa. International Journal of Eating Disorders, 20, 359–365.

    CAS  PubMed  Google Scholar 

  • Williams, S. (2005). Medications for treating alcohol dependence. American Family Physician, 72, 1775–1780.

    PubMed  Google Scholar 

  • Yeo, K.-K., Wijetunga, M., Ito, H., Efird, J., Tay, K., Seto, T., … Schatz, I. (2007). The association of methamphetamine use and cardiomyopathy in young patients. American Journal of Medicine, 120, 165–171.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry and Behavioral Neurosciences, University of South Florida, Tampa, FL, USA

    Amy Baker Dennis

  2. Dennis & Moye & Associates, 1750 S. Telegraph Rd. #101, Bloomfield Hills, MI, 48302, USA

    Amy Baker Dennis

  3. Department of Psychiatry, University of Kansas School of Medicine, Wichita, KS, USA

    Tamara Pryor

  4. Eating Disorder Center of Denver, Denver, CO, USA

    Tamara Pryor

Authors
  1. Amy Baker Dennis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Tamara Pryor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amy Baker Dennis .

Editor information

Editors and Affiliations

  1. Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, South Carolina, USA

    Timothy D. Brewerton

  2. Psychiatry and Behavioral Neurosciences, University of South Florida, Bloomfield Hills, Michigan, USA

    Amy Baker Dennis

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dennis, A.B., Pryor, T. (2014). Introduction to Substance Use Disorders for the Eating Disorder Specialist. In: Brewerton, T., Baker Dennis, A. (eds) Eating Disorders, Addictions and Substance Use Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-45378-6_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-45378-6_12

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-45377-9

  • Online ISBN: 978-3-642-45378-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation